W
Werner Hacke
Researcher at Heidelberg University
Publications - 688
Citations - 93115
Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.
Papers
More filters
Journal ArticleDOI
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: Results from the ROCKET AF trial
Kenneth W. Mahaffey,Susanna R. Stevens,Harvey D. White,Christopher C. Nessel,Shaun G. Goodman,Jonathan P. Piccini,Manesh R. Patel,Richard C. Becker,Jonathan L. Halperin,Werner Hacke,Daniel E. Singer,Graeme J. Hankey,Robert M. Califf,Keith A.A. Fox,Günter Breithardt +14 more
TL;DR: Prior MI was common and associated with substantial risk for subsequent cardiac events and patients with prior MI assigned rivaroxaban compared with warfarin had a non-significant 14% reduction of ischaemic cardiac events.
Journal ArticleDOI
Hemicraniectomy with dural augmentation in medically uncontrollable hemispheric infarction.
Christian Rainer Wirtz,Thorsten Steiner,Alfred Aschoff,Stefan Schwab,Holger Schnippering,Hans H. Steiner,Werner Hacke,Stefan Kunze +7 more
TL;DR: It is concluded that decompressive craniectomy is an effective treatment, able to reduce mortality, and to improve neurological outcome in patients with space-occupying cerebral infarction if the size of crANIectomy is large enough.
Journal ArticleDOI
Therapeutic Strategies in Space-Occupying Cerebellar Infarction Based on Clinical, Neuroradiological and Neurophysiological Data
TL;DR: The analysis of the preliminary data suggests surgical decompression of the posterior fossa as the optimum therapeutic regimen in obtunded patients presenting with occlusive hydrocephalus and signs of brainstem compression.
Journal ArticleDOI
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial
Thomas H. Wang,Deepak L. Bhatt,Keith A.A. Fox,Steven R. Steinhubl,Danielle M. Brennan,Werner Hacke,Koon-Hou Mak,Thomas A. Pearson,William E. Boden,P. Gabriel Steg,Marcus Flather,Gilles Montalescot,Eric J. Topol +12 more
TL;DR: Findings do not support the use of dual-antiplatelet therapy with clopidogrel and aspirin in a primary prevention population and the cause of this apparent harm is not elucidated, may represent play of chance, but requires further prospective evaluation.
Journal ArticleDOI
Predominant involvement of motor fibres in patients with critical illness polyneuropathy.
TL;DR: It is concluded that CIP is a major complication in patients with severe sepsis and prolonged artificial ventilation and predominantly involves motor fibres and thus markedly interferes with weaning from the ventilator.